“I’m extremely pleased with our outstanding second quarter results, which further demonstrate the success of our diversification strategy,” said CEO Mark Mondello. “Quite simply, our approach is working, both in terms of our strategy and operational excellence. This is well-illustrated by our performance in the first half of the fiscal year.”
The company reported second quarter of fiscal year 2019 net revenue of $6.1 billion. Diversified Manufacturing Services (DMS) year-on-year revenue decrease was 7%, while Electronics Manufacturing Services (EMS) year-on-year revenue growth was 33%. US GAAP operating income was $154 million.
During the second fiscal quarter, Jabil successfully transitioned the first two sites from Johnson & Johnson Medical Devices Companies (JJMDC) as part of the previously announced strategic collaboration between the companies.
“As we move into the back half of our fiscal year, our outlook for revenue and core EPS remain strong, supported by strength in our healthcare, retail, cloud and industrial businesses,” said Mondello.